We are live on ! Find out more
EA

Emerald Advisers Portfolio holdings

AUM $3.16B
1-Year Est. Return 109.58%
This Fund
S&P 500
This Quarter Est. Return
+13.92%
1 Year Est. Return
+109.58%
3 Year Est. Return
+352.93%
5 Year Est. Return
+451.34%
10 Year Est. Return
+3,577.15%
AUM
$2.07B
AUM Growth
+$131M
Cap. Flow
-$8.41M
Cap. Flow %
-0.41%
Top 10 Hldgs %
17.49%
Holding
270
New
21
Increased
72
Reduced
124
Closed
24

Top Buys

Rank Stock Value
1
INSM icon
Insmed
INSM
+$19.2M
2
CHX
ChampionX
CHX
+$16.3M
3
MRCY icon
Mercury Systems
MRCY
+$15.2M
4
AVAV icon
AeroVironment
AVAV
+$15M
5
AQUA
Evoqua Water Technologies Corp. Common Stock
AQUA
+$11.6M

Top Sells

Rank Stock Value
1
ITGR icon
Integer Holdings
ITGR
+$17.9M
2
TNDM icon
Tandem Diabetes Care
TNDM
+$14.3M
3
PCRX icon
Pacira BioSciences
PCRX
+$13.1M
4
HRT
HireRight Holdings Corporation
HRT
+$12.9M
5
IMGO
Imago BioSciences, Inc. Common stock
IMGO
+$12.8M

Sector Composition

Rank Sector Weight
1 Healthcare 30.79%
2 Industrials 15.85%
3 Consumer Discretionary 14.25%
4 Technology 13.06%
5 Financials 7.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EE icon
51
Excelerate Energy
EE
$1.24B
$17.5M 0.84%
697,438
+3,533
+0.5% +$92.7K
AMRC icon
52
Ameresco
AMRC
$1.22B
$17.4M 0.84%
304,724
+114,765
+60% +$6.99M
BPMC
53
DELISTED
Blueprint Medicines
BPMC
$17.1M 0.83%
391,156
+72,582
+23% +$3.48M
CHX
54
DELISTED
ChampionX
CHX
$17.1M 0.82%
+588,835
New +$16.3M
ALKS icon
55
Alkermes
ALKS
$8.79B
$16.7M 0.81%
639,430
+338,136
+112% +$8.09M
RXDX
56
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
$16.5M 0.8%
+149,689
New +$9.71M
ISEE
57
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$16.3M 0.79%
760,044
-202,863
-21% -$4.33M
HLI icon
58
Houlihan Lokey
HLI
$9.67B
$16.1M 0.78%
184,286
+586
+0.3% +$52.7K
BJRI icon
59
BJ's Restaurants
BJRI
$1.42B
$16.1M 0.78%
608,545
+68,369
+13% +$2M
CUBI icon
60
Customers Bancorp
CUBI
$2.65B
$16M 0.78%
566,076
+29,911
+6% +$932K
RARE icon
61
Ultragenyx Pharmaceutical
RARE
$2.88B
$16M 0.77%
344,725
-2,356
-0.7% -$92.7K
AVAV icon
62
AeroVironment
AVAV
$7.2B
$15M 0.73%
+175,523
New +$15M
CUTR
63
DELISTED
Cutera, Inc.
CUTR
$14.9M 0.72%
337,182
-140,651
-29% -$6.41M
ARIS
64
DELISTED
Aris Water Solutions
ARIS
$14.9M 0.72%
1,034,058
+25,904
+3% +$398K
CCOI icon
65
Cogent Communications
CCOI
$549M
$14.5M 0.7%
253,719
+3,050
+1% +$167K
MRCY icon
66
Mercury Systems
MRCY
$5.77B
$14.4M 0.7%
+321,964
New +$15.2M
VC icon
67
Visteon
VC
$2.8B
$14M 0.68%
106,872
-18,215
-15% -$2.43M
PTLO icon
68
Portillo's
PTLO
$338M
$14M 0.68%
856,424
+115,300
+16% +$2.31M
HAE icon
69
Haemonetics
HAE
$3.54B
$13.9M 0.67%
176,174
-145,097
-45% -$11.7M
COHR icon
70
Coherent
COHR
$54.3B
$13.8M 0.66%
392,035
+175,950
+81% +$6.12M
RPD icon
71
Rapid7
RPD
$815M
$13.1M 0.63%
385,779
-101,018
-21% -$3.61M
DCGO icon
72
DocGo
DCGO
$64.3M
$13M 0.63%
1,841,338
-13,054
-0.7% -$110K
WOOF icon
73
Petco
WOOF
$760M
$12.6M 0.61%
1,330,663
-40,975
-3% -$420K
AIMC
74
DELISTED
Altra Industrial Motion Corp
AIMC
$12.3M 0.6%
206,124
-13,394
-6% -$703K
ARVN icon
75
Arvinas
ARVN
$517M
$12.3M 0.59%
359,483
+39,746
+12% +$1.67M
1 2
3
4 5

Similar funds

AWE
Avidian Wealth Enterprises Houston, Texas $3.16B AUM 20.31% 1-Year Est. Return
FTUS
Flow Traders U.S. New York $3.16B AUM 19.52% 1-Year Est. Return
BFA
Bragg Financial Advisors Charlotte, North Carolina $3.16B AUM 26% 1-Year Est. Return
BP
BNP Paribas Paris, France $3.15B AUM 22.54% 1-Year Est. Return
CVA
Ceredex Value Advisors Orlando, Florida $3.18B AUM 35.23% 1-Year Est. Return
DWP
Daymark Wealth Partners Cincinnati, Ohio $3.18B AUM 23.46% 1-Year Est. Return
GKWIM
Gerber Kawasaki Wealth & Investment Management Santa Monica, California $3.14B AUM 22.62% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Emerald Advisers's Q4 2022 Portfolio in Review

As of Q4 2022, Emerald Advisers held 270 positions worth $2.07B, up 6.8% from $1.94B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Emerald Advisers's Q4 2022 filing shows 21 new, 72 increased, 124 reduced and 24 closed positions. Its largest new stake was Insmed: 994,913 shares worth $19.9M. The largest sale was Integer Holdings, an estimated $17.9M.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, up from 31% a quarter earlier, followed by Industrials and Consumer Discretionary.

  • Emerald Advisers's largest Q4 2022 buy was Insmed: 994,913 shares worth $19.9M.
  • Emerald Advisers added most to Evoqua Water Technologies Corp. Common Stock in Q4 2022, an estimated $11.6M increase.
  • Emerald Advisers's biggest Q4 2022 reduction was Integer Holdings, cutting an estimated $17.9M.
  • Emerald Advisers fully exited Tandem Diabetes Care in Q4 2022, selling an estimated $14.3M.
  • Emerald Advisers's ten largest holdings make up 17% of its $2.07B portfolio in Q4 2022.
  • Emerald Advisers opened 21 new positions and closed 24 in Q4 2022.
  • Emerald Advisers's portfolio value rose 6.8% quarter-over-quarter to $2.07B.

Based on Emerald Advisers's 13F filing for Q4 2022, filed 3 Feb 2023.